The TSP motif in AP180 inhibits phospholipase D1 activity resulting in increased efficacy of anticancer drug via its direct binding to carboxyl terminal of phospholipase D1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples